Zhao Hui Zhang
Founder chez WUXI PHARMATECH (CAYMAN) INC. (ADR)
Fortune : - $ au 31/03/2024
Postes actifs de Zhao Hui Zhang
Sociétés | Poste | Début | Fin |
---|---|---|---|
WUXI PHARMATECH (CAYMAN) INC. (ADR) | Director/Board Member | 01/01/2000 | - |
Founder | 01/01/2000 | - | |
Corporate Officer/Principal | 01/01/2000 | - | |
Sales & Marketing | 03/04/2012 | - | |
WUXI APPTEC CO., LTD. | Director/Board Member | 01/12/2000 | - |
Founder | 01/12/2000 | - | |
Corporate Officer/Principal | 06/06/2023 | - | |
General Counsel | 01/12/2000 | 06/06/2023 | |
Shanghai Syn-the-all Pharmaceutical Co. Ltd.
Shanghai Syn-the-all Pharmaceutical Co. Ltd. Pharmaceuticals: GenericHealth Technology Shanghai Syn-the-all Pharmaceutical Co. Ltd. engages in the manufacture, research and development of generic drugs. The company offers active pharmaceutical ingredients and finished forms. It provides API process development, small molecule Active pharmaceutical ingredients, analytical development and quality control, antibody drug conjugate services. It serves life science industry. Shanghai Syn-the-all Pharmaceutical was founded on January 23, 2003 and is headquartered in Shanghai, China. | Director/Board Member | 02/11/2017 | - |
Wuxi Qingye Investment Consultancy Ltd. | Chief Executive Officer | 01/01/2000 | - |
Historique de carrière de Zhao Hui Zhang
Anciens postes connus de Zhao Hui Zhang
Sociétés | Poste | Début | Fin |
---|---|---|---|
CHINA NATIONAL MEDICINES CORPORATION LTD. | Director/Board Member | 25/05/2010 | - |
WUXI BIOLOGICS (CAYMAN) INC. | Director/Board Member | - | - |
American Silver Bell Co. | Corporate Officer/Principal | - | - |
Formation de Zhao Hui Zhang
China Europe International Business School | Masters Business Admin |
Jiangnan University | Undergraduate Degree |
Statistiques
Internationale
Chine | 9 |
Etats-Unis | 2 |
Opérationnelle
Director/Board Member | 5 |
Corporate Officer/Principal | 3 |
Founder | 2 |
Sectorielle
Health Technology | 6 |
Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 3 |
---|---|
CHINA NATIONAL MEDICINES CORPORATION LTD. | Health Technology |
WUXI APPTEC CO., LTD. | Health Technology |
WUXI BIOLOGICS (CAYMAN) INC. | Health Technology |
Entreprise privées | 4 |
---|---|
Wuxi PharmaTech (Cayman), Inc.
Wuxi PharmaTech (Cayman), Inc. Pharmaceuticals: MajorHealth Technology Wuxi PharmaTech (Cayman), Inc. engages in the provision of research and development outsourcing services for the pharmaceutical, biotechnology and medical device industries. It operates through the laboratory services and manufacturing services segments. The laboratory services segment offers pharmaceutical and biotech services including discovery and medicinal chemistry, discovery biology, safety pharmacology, bioanalytical services, process research, formulation and toxicology laboratory services, as well as testing services for biologics, medical devices and combination products. The manufacturing services segment involves the production of intermediates and active pharmaceutical ingredients for or preclinical and clinical trials of small-molecule and commercial products; and biologics. The company was founded by Ge Li, Xiao Zhong Liu, Zhao Hui Zhang and Ning Zhao in 2000 and is headquartered in Shanghai, China. | Health Technology |
American Silver Bell Co. | |
Shanghai Syn-the-all Pharmaceutical Co. Ltd.
Shanghai Syn-the-all Pharmaceutical Co. Ltd. Pharmaceuticals: GenericHealth Technology Shanghai Syn-the-all Pharmaceutical Co. Ltd. engages in the manufacture, research and development of generic drugs. The company offers active pharmaceutical ingredients and finished forms. It provides API process development, small molecule Active pharmaceutical ingredients, analytical development and quality control, antibody drug conjugate services. It serves life science industry. Shanghai Syn-the-all Pharmaceutical was founded on January 23, 2003 and is headquartered in Shanghai, China. | Health Technology |
Wuxi Qingye Investment Consultancy Ltd. |
- Bourse
- Insiders
- Zhao Hui Zhang
- Expérience